Home » Newsletters » BioWorld Science

BioWorld Science

June 14, 2000

View Archived Issues

Isis and Elan joint venture moves ISIS-104838 towards clinical development

Technology to blueprint infectious diseases developed at Antex

Trial of therapeutic agent for myelodysplastic syndrome indicates even greater potential

Study confirms VasoCare's ability to improve blood vessel function in atherosclerosis

Medarex and Corixa form alliance for therapeutic monoclonal antibodies

Schering AG, Epix and Mallinckrodt collaborate on cardiovascular MRI agents

Tenilsetam is an effective AGE inhibitor and prevents diabetic retinopathy in animals

GT-015 endowed with both neuroprotective and cognition-enhancing properties

Aventis presents novel modified insulin analogue at ADA meeting

Anticoagulant and antithrombotic effects of PD-200022 reported at ASBMB/ASPET

Phase III results for fidarestat presented this week in San Antonio

New directions in diabetes research: Telik presents at ADA

Pharmacological testing of E-2101 demonstrates central muscle relaxant and analgesic effects

Recent data on KT-5720 confirm its ability to reverse morphine tolerance

Ligand develops retinoid X receptor agonist for diabetes

New thiourea designed by Parker Hughes active against multidrug-resistant HIV-1

Japanese investigators isolate new type of antiinflammatory peptide

News from ADA: CS-011 is a promising new thiazolidinedione antidiabetic

Metamizole: controlled-release tablets described by Italian laboratory

Venlafaxine effective in the treatment of painful diabetic neuropathy

Combination therapy for HCV, particularly following liver transplant, patented

Novel PGI2 derivatives from Toray active against H. pylori

Integrin-inhibitory chromenone and chromanone derivatives synthesized at Merck

Novo Nordisk prepares orally available GH-releasing agents

Highly potent and selective COX-2 inhibitors emerge from Glaxo Wellcome R&D

Thrombin inhibitors from Merck reported to have nanomolar inhibitory activity

Merck presents two new series of potassium channel blockers for autoimmune diseases, arrhythmias

JP-1730 may represent a useful treatment option for Parkinson's

Further evidence presented at ongoing meeting supporting utility of (-)-OSU-6162 in PD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...